S, O., S, A., C, C., M, G., P, N., & F, C. (2014). Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV. BMC infectious diseases, 14 Suppl 5, S4. https://doi.org/10.1186/1471-2334-14-S5-S4
Chicago Style (17th ed.) CitationS, Odolini, Amadasi S, Cerini C, Giralda M, Nasta P, and Castelli F. "Sustained Virological Response to Peginterferon Therapy in Patients Infected with HCV (genotypes 2 and 3), with or Without HIV." BMC Infectious Diseases 14 Suppl 5 (2014): S4. https://doi.org/10.1186/1471-2334-14-S5-S4.
MLA (9th ed.) CitationS, Odolini, et al. "Sustained Virological Response to Peginterferon Therapy in Patients Infected with HCV (genotypes 2 and 3), with or Without HIV." BMC Infectious Diseases, vol. 14 Suppl 5, 2014, p. S4, https://doi.org/10.1186/1471-2334-14-S5-S4.